- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
The study of pirarubicin-emulsion for hepatic arterial infusion chemotherapy.
-
- Nakao Takuma
- Process Development Laboratories, Mercian Corporation
-
- Johdo Osamu
- Process Development Laboratories, Mercian Corporation
-
- Iguchi Hiroshi
- Central Research Laboratories, Mercian Corporation
-
- Yoshioka Takeo
- Central Research Laboratories, Mercian Corporation
-
- Katoh Masashi
- Division of Pharmacy, Niigata University Medical Hospital
-
- Satoh Hiroshi
- Division of Pharmacy, Niigata University Medical Hospital
-
- Tanno Keiki
- Division of Pharmacy, Niigata University Medical Hospital
-
- Ichida Takafumi
- The Third Department of Internal Medicine, Niigata University School of Medicine
-
- Asakura Hitoshi
- The Third Department of Internal Medicine, Niigata University School of Medicine
Bibliographic Information
- Other Title
-
- 肝細胞癌動注化学療法に用いるピラルビシン(THP)・エマルジョンの基礎的検討
Search this article
Description
To develop new dosage form of pirarubicin (THP) for hepatic arterial infusion chemotherapy, we investigated constituents of THP-emulsion, stability of THP in emulsions, and release characteristics of THP from emulsions. The THP-emulsion was prepared by high pressure homogenization using three-way cock. Water and non-ionic contrast media (CM), which are Iopamidol, Iohexol and Ioversol, were used as solvents for THP. Sesame oil, soybean oil, and Lipiodol-ultrafluid (LPD) were used as oily phase, and surfactants and saccharides were used as additives to make the emulsion stable. Stable w/o and o/w types of emulsions were obtained only when THP was dissolved in CM and mixed with LPD. Stability of THP in CM was examined and Iopamidol (Iopamiron 300) was selected as the solvent. Release characteristics of THP from the emulsion consisted of Iopamiron 300 and LPD was examined by means of multistoried method using saline. THP was released rapidly from the o/w type of emulsion, but gradually from the w/o type of emulsion. In this study, we could propose o/w and w/o types of THP-emulsions using Iopamiron 300 and LPD as constituents to carry preclinical study for hepatic arterial infusion chemotherapy.
Journal
-
- Drug Delivery System
-
Drug Delivery System 12 (6), 421-430, 1997
THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679617929344
-
- NII Article ID
- 10007337719
-
- NII Book ID
- AN10084591
-
- ISSN
- 18812732
- 09135006
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed